» Articles » PMID: 33121939

Re: Nizar M. Tannir, Sabina Signoretti, Toni K. Choueiri, Et Al. Efficacy and Safety of Nivolumab Plus Ipilimumab Versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma. Clin Cancer Res. In Press....

Overview
Journal Eur Urol Oncol
Specialties Oncology
Urology
Date 2020 Oct 30
PMID 33121939
Authors
Affiliations
Soon will be listed here.
Citing Articles

First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis.

Aldin A, Besiroglu B, Adams A, Monsef I, Piechotta V, Tomlinson E Cochrane Database Syst Rev. 2023; 5():CD013798.

PMID: 37146227 PMC: 10158799. DOI: 10.1002/14651858.CD013798.pub2.